Heba Abdel-Halim

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Pseudomonas Aeruginosa

Molecular Dynamics Simulations

Top Venues

Microbial drug resistance (Larchmont, N.Y.)

Applied microbiology and biotechnology

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Suzanne M A Abdelmalek, Malak Hajar, Luma Salah, Heba Abdel-Halim
In Silico Screening and Experimental Validation of Novel MexAB-OprM Efflux Pump Inhibitors of Pseudomonas aeruginosa . Microbial drug resistance (Larchmont, N.Y.) 30 (2) (2023)
Suzanne M A Abdelmalek, Malak Hajar, Luma Salah, Heba Abdel-Halim
In Silico Screening and Experimental Validation of Novel MexAB-OprM Efflux Pump Inhibitors of Pseudomonas aeruginosa . Microbial drug resistance (Larchmont, N.Y.) 30 (2) (2023)
Suzanne M A Abdelmalek, Malak Hajar, Luma Salah, Heba Abdel-Halim
In Silico Screening and Experimental Validation of Novel MexAB-OprM Efflux Pump Inhibitors of Pseudomonas aeruginosa . Microbial drug resistance (Larchmont, N.Y.) (2023)
Heba Abdel-Halim, Malak Hajar, Luma Hasouneh, Suzanne M A Abdelmalek
Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach. Drug design, development and therapy 16 (2022)
Heba Abdel-Halim, Ala'a Al Dajani, Abeer Abdelhalim, Suzanne Abdelmalek
The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach. Applied microbiology and biotechnology 103 (15) (2019)